For Immediate Release

Media Contact:
Name:             Ron Wilson
Title:                Director of Marketing
Phone:             310-642-2122
Adexa Planning Solution Selected by Allergan to Optimize Operation
Deployment of Adexa in Allergan’s complex pharmaceutical operations marks a major breakthrough in  how the industry plans its operations.
Los Angeles, CA – May, 2017 – One of Forbes world’s largest public drug and biotech companies, Allergan, is now using Adexa’s planning solution in order to plan and optimize their production environment. The model maximizes the use of available capacity while minimizing cost. Given the high asset-intensive production sites of the company as well as complexity of their operations, Adexa was selected for its unique ability to model their mixed mode (discrete and process) environment very closely and scale to their operation with high levels of accuracy. The implementation which is expected to take only a few months will enable the company to operate at a much lower cost while ensuring on-time delivery of the products and maximal use of resources 

We are extremely pleased to have partnered with such a visionary and one of the world’s best pharmaceutical companies.” Commented John Hosford, VP Services and Solutions Delivery. “ We are very grateful for the trust and confidence that Allergan has granted Adexa to run their day-to-day planning operation.” 
About Adexa, Inc.
Adexa delivers intelligent enterprise business planning and performance management solutions that link strategic planning, financial planning and supply chain planning.  In this synchronized environment, the financial impact of planning decisions, and their ramifications on the enterprise, are known in advance to ensure profitable decisions are made every time.  The end result is an innovative enterprise, able to proactively adjust to changing market conditions and support growth and capitalization. Visit:
About  Allergan
Allergan plc is a global pharmaceutical company. The Company is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. The Company is also focused on developing, manufacturing and commercializing select over-the-counter (OTC) products. The Company markets a portfolio of products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories. For more information: